TD Asset Management Inc Cuts Position in HCA Healthcare, Inc. $HCA

TD Asset Management Inc decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 7.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 522,648 shares of the company’s stock after selling 39,596 shares during the period. TD Asset Management Inc owned approximately 0.23% of HCA Healthcare worth $244,003,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Nordea Investment Management AB lifted its holdings in HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after buying an additional 108,849 shares during the period. Savant Capital LLC lifted its holdings in HCA Healthcare by 37.7% in the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after buying an additional 1,246 shares during the period. Hudson Bay Capital Management LP lifted its holdings in HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after buying an additional 2,849 shares during the period. Advisors Capital Management LLC lifted its holdings in HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares during the period. Finally, CWA Asset Management Group LLC lifted its holdings in HCA Healthcare by 1,062.4% in the fourth quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after buying an additional 8,733 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $364.00 on Thursday. The stock has a 50-day moving average price of $444.21 and a 200-day moving average price of $478.72. The firm has a market cap of $80.75 billion, a PE ratio of 12.52, a P/E/G ratio of 1.16 and a beta of 1.12. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s payout ratio is currently 10.73%.

Wall Street Analyst Weigh In

Several brokerages have commented on HCA. KeyCorp lowered their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Sanford C. Bernstein lowered their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a report on Tuesday, April 28th. Robert W. Baird lowered their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Wells Fargo & Company lowered their price target on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research report on Monday, April 27th. Finally, Jefferies Financial Group reissued a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $515.77.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.